WO2023046321 - PHARMACEUTICAL FORMULATION COMPRISING TACROLIMUS, METHOD FOR THE PREPARATION THEREOF AND USE
National phase entry:
Publication Number
WO/2023/046321
Publication Date
30.03.2023
International Application No.
PCT/EP2022/025445
International Filing Date
27.09.2022
Title **
[English]
PHARMACEUTICAL FORMULATION COMPRISING TACROLIMUS, METHOD FOR THE PREPARATION THEREOF AND USE
[French]
FORMULATION PHARMACEUTIQUE COMPRENANT DU TACROLIMUS, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
Applicants **
PHARMATHEN S.A.
Inventors
KARAVAS, Evangelos
KOUTRIS, Efthymios
KALANTZI, Lida
CHAITIDOU, Sotiria
LEMONAKIS, Nikos
PAPADAKI, Anna
BRIEUDES, Vincent
KALEZI, Artemis
KATSENIS, Athanasios
KOTTI, Katerina
Priority Data
20210100639
27.09.2021
GR
2116138.5
10.11.2021
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
* |
| Recordal of a Change of the Applicant's Name/Address | * |
| Type of Assignment | * |
| Applicant's Legal Status | * |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under | * |
| Patent Delivery | * |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2460 | |
| EPO | Filing, Examination, Granting | 14416 | |
| Japan | Filing, Examination, Granting | 2634 | |
| South Korea | Filing, Examination, Granting | 3158 | |
| USA | Filing, Examination, Granting | 7340 |
Total:
30,008
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a long acting injectable formulation based on combination of biodegradable poly(D,L-lactide-co-glycolide) microparticles comprising different PLGA polymers and Tacrolimus. It also relates to a process for the preparation of microparticles & use thereof.[French]
La présente invention concerne une formulation injectable à action prolongée basée sur la combinaison de microparticules biodégradables de poly(D,L-lactide-co-glycolide) comprenant différents polymères de PLGA et du Tacrolimus. L'invention concerne également un procédé de préparation de microparticules et son utilisation.